RNF213 variant and autophagic impairment: A pivotal link to endothelial dysfunction in moyamoya disease.
Article in Cerebrovascular and Brain Metabolism Reviews (April 2024)
The most recent citing publications are shown below. View all 15 publications that cite this research output on Dimensions.
Transcriptomic analysis reveals Cilostazol's role in ameliorating cardiovascular disease: Inhibition of monocyte-to-macrophage differentiation and reduction of endothelial cell reactive oxygen species production
Article in Heliyon (April 2024)
The Role of Cilostazol, a Phosphodiesterase-3 Inhibitor, in the Development of Atherosclerosis and Vascular Biology: A Review with Meta-Analysis
Article in International Journal of Molecular Sciences (February 2024)